Pediatric Dermatology

Papers
(The TQCC of Pediatric Dermatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Chilblains in children in the setting of COVID‐19 pandemic143
Erythema multiforme‐like lesions in children and COVID‐1993
Varicella‐like exanthem associated with COVID‐19 in an 8‐year‐old girl: A diagnostic clue?79
Chilblain‐like lesions in children following suspected COVID‐19 infection78
Clustered cases of acral perniosis: Clinical features, histopathology, and relationship to COVID‐1977
Acne and social media: A cross‐sectional study of content quality on TikTok54
Disparities in telemedicine access for Spanish‐speaking patients during the COVID‐19 crisis33
Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents28
Recurrent reactive infectious mucocutaneous eruption (RIME): Insights from a child with three episodes26
Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study26
Management of infantile hemangiomas during the COVID pandemic25
Propranolol‐resistant infantile hemangioma successfully treated with sirolimus25
Epidermolysis bullosa pruriginosa treated with dupilumab25
Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: Systematic review and meta‐analysis25
Juvenile xanthogranulomas: Examining single, multiple, and extracutaneous presentations23
Psoriasiform dermatitis during dupilumab treatment for moderate‐to‐severe atopic dermatitis in children23
Vulvar aphthous ulcer after COVID‐19 vaccination21
Rash as a presenting complaint in a child with COVID‐1921
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data21
Netherton syndrome: Temporary response to dupilumab20
Fractional CO2 laser‐assisted topical rifamycin drug delivery in the treatment of pediatric cutaneous leishmaniasis19
Successful management of an arteriovenous malformation with trametinib in a patient with capillary‐malformation arteriovenous malformation syndrome and cardiac compromise19
The geographic distribution of the US pediatric dermatologist workforce: A national cross‐sectional study19
Staphylococcal scalded skin syndrome: An epidemiological and clinical review of 84 cases19
Differences between pediatric and adult atopic dermatitis18
Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database17
Successful treatment of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome with tofacitinib17
Pediatric dermatology eConsults: Reduced wait times and dermatology office visits17
Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi‐center retrospective case series16
Henoch‐Schönlein purpura: Another COVID‐19 complication16
Pediatric teledermatology: A review of the literature16
Langerhans cell histiocytosis in children: A retrospective case series of 126 cases15
A network meta‐analysis on the efficacy and safety of monotherapies for tinea capitis, and an assessment of evidence quality15
CARD14‐associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature15
Dermatologic conditions in Down syndrome: A single‐center retrospective chart review14
Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: Clinical aspects and treatment outcomes in adolescent and adult patients14
“COVID toes”: A meta‐analysis of case and observational studies on clinical, histopathological, and laboratory findings14
Poster Presentations14
Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS‐CoV‐2 and influenza A13
Implementation of a pediatric provider‐to‐provider store‐and‐forward teledermatology system: Effectiveness, feasibility, and acceptability in a pilot study13
Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child13
Dupilumab for pediatric prurigo nodularis: A case report13
Hair and skin predict cardiomyopathies: Carvajal and erythrokeratodermia cardiomyopathy syndromes12
Oral tofacitinib for the treatment of alopecia areata in pediatric patients12
New‐onset head and neck dermatitis in adolescent patients after dupilumab therapy for atopic dermatitis12
Pediatric hematidrosis – A case report and review of the literature and pathogenesis12
Financial burden of epidermolysis bullosa on patients in the United States12
Use of spironolactone to treat acne in adolescent females12
Gamification improves melanoma visual identification among high school students: Results from a randomized study11
Evaluation of electronic consults for outpatient pediatric patients with dermatologic complaints11
Teledermatology: How It Is Impacting the Underserved11
Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research all11
Adenoviral‐induced rash and mucositis: Expanding the spectrum of reactive infectious mucocutaneous eruption11
TH2 sensitization in the skin‐gut‐brain axis: How early‐life Th2‐mediated inflammation may negatively perpetuate developmental and psychologic abnormalities11
Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study11
Infliximab therapy in an infant with Netherton syndrome10
Biologics for pediatric psoriasis: A systematic review and meta‐analysis10
A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children10
Gianotti‐crosti syndrome in the setting of recent coronavirus disease‐19 infection10
Clinical features of recurrent Mycoplasma pneumoniae–induced rash and mucositis10
Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab10
Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa10
Predictors and age‐dependent pattern of psychologic problems in childhood atopic dermatitis10
Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: A retrospective analysis10
A practical review of dermoscopy for pediatric dermatology part II: Vascular tumors, infections, and inflammatory dermatoses10
Tinea capitis: An update10
Prevalence of inflammatory bowel disease among pediatric patients with hidradenitis suppurativa and the potential role of screening with fecal calprotectin10
Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus‐based guidance for clinical decision‐making during the COVID‐19 pandemic10
Assessing vaccination reactions in pediatric patients with maculopapular cutaneous mastocytosis10
Bier anemic spots, cyanosis, and urticaria‐like eruption (BASCULE) syndrome: Report of two new cases and literature review10
Using cold plasma to treat warts in children: A case series10
The anatomic distribution of isolated and syndrome‐associated port‐wine stain10
Reactive infectious mucocutaneous eruption in children diagnosed with COVID‐199
Monkeypox disease in a breastfeeding infant9
Barriers to healthcare access in pediatric dermatology: A systematic review9
Understanding sunscreen and photoprotection misinformation on parenting blogs: A mixed‐method study9
Hidradenitis suppurativa and Down syndrome: A systematic review and meta‐analysis9
Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events9
Association between atopic dermatitis and headaches throughout childhood and adolescence—A longitudinal birth cohort study9
Linear porokeratosis with bone abnormalities treated with compounded topical 2% cholesterol/2% lovastatin ointment9
Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach‐Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus9
A sixteen‐year single‐center retrospective chart review of Spitz nevi and spitzoid neoplasms in pediatric patients9
Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders9
Weight counseling in pediatric hidradenitis suppurativa patients9
Spectrum of autoimmune bullous diseases among children in Kuwait9
When is synchronous telehealth acceptable for pediatric dermatology?9
Papulo‐purpuric dermatitis of childhood: a distinct PLEVA‐like eruption associated to SARS‐CoV‐2 infection. Clinical, histopathological and immunohistochemical study of 10 cases9
Dermatofibrosarcoma protuberans, fibrosarcomatous variant: A rare tumor in children8
Methylisothiazolinone in children’s nail polish8
Epidermolysis bullosa simplex due to bi‐allelic DST mutations: Case series and review of the literature8
Chilblains in children in the time of COVID‐19: New evidence with serology assay8
Paradoxical psoriasis in pediatric patients: A systematic review8
The positive environmental impact of virtual isotretinoin management8
Dermatologic conditions in Down syndrome8
A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome8
Primary hyperhidrosis in children: A review of therapeutics8
Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation8
Epidermolysis bullosa with congenital absence of skin: Review of the literature8
Evaluation of emergency department utilization for dermatologic conditions in the pediatric population within the United States from 2009‐20158
Cutaneous body image: A window into the adolescent experience of dermatologic disease8
Comment on “Chilblains‐like lesions in children following suspected COVID‐19 infection”8
POSTER PRESENTATIONS8
Levetiracetam‐induced pediatric toxic epidermal necrolysis successfully treated with etanercept8
Contrasting readability and availability of Spanish language with English language patient education materials8
Recurrent angioedema in childhood: hereditary angioedema or histaminergic angioedema?7
Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol7
Comparison of lichen sclerosus in boys and girls: A systematic literature review of epidemiology, symptoms, genetic background, risk factors, treatment, and prognosis7
Clearance of recalcitrant warts in a pediatric patient following administration of the nine‐valent human papillomavirus vaccine7
Geographic distribution and characteristics of the pediatric dermatology workforce in the United States7
Pellagra secondary to selective eating in a child with autism7
Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases7
Use of an emollient‐containing diaper and pH‐buffered wipe regimen restores skin pH and reduces residual enzymatic activity7
Long‐term sirolimus treatment in blue rubber bleb nevus syndrome: Case report and review of the literature7
Filling in the gaps on FILS syndrome: A case report and literature review7
Metastatic neuroblastoma mimicking an infantile hemangioma7
Two cases of CARD14‐associated papulosquamous eruption from India7
Publication productivity (H‐Index) among pediatric dermatologists in the United States7
Nevus comedonicus syndrome: A systematic review of the literature7
Clearance of pediatric actinic prurigo with dupilumab7
Chronic urticaria in children under 15 years of age: Clinical experience beyond the clinical trials7
Photographic representation of skin tones in three dermatology journals7
Review of traction alopecia in the pediatric patient: Diagnosis, prevention, and management7
Keratosis pilaris‐like eruption secondary to nilotinib in a child7
Acute urticaria preceding other COVID‐19–associated manifestations—A case report7
Clinical and genetic evaluation of six children with diffuse capillary malformation and undergrowth7
Evaluation of neurodevelopmental symptoms in 10 cases of neonatal ichthyosis and sclerosing cholangitis syndrome7
Suspected COVID‐19‐related reticulated purpura of the soles in an infant7
BASCULE syndrome in a child with prior asymptomatic COVID‐19 infection6
Propranolol's effects on the sleep of infants with hemangiomas: A prospective pilot study6
Learning to pop blisters in epidermolysis bullosa with a simple model6
Improving newborn skin health: Effects of diaper care regimens on skin pH and erythema6
Retrospective review of confluent and reticulated papillomatosis in pediatric patients6
Light‐based treatment of pediatric port‐wine birthmarks6
Toxic epidermal necrolysis after first dose of Pfizer‐BioNTech (BNT162b2) vaccination with pharmacogenomic testing6
Language‐centered approach to care improvement in a pediatric dermatology clinic6
Patient‐reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross‐sectional survey6
Readability of online patient education materials for juvenile dermatomyositis6
Ultraviolet filters in sunscreen products labeled for use in children and for sensitive skin6
Treatment practices in the management of scabies in infants younger than two months6
Dermatofibrosarcoma protuberans (DFSP) in children: A combined multidisciplinary approach6
Dermatologic considerations for transgender and gender diverse youth6
Pediatric maculopapular cutaneous mastocytosis: Retrospective review of signs, symptoms, and associated conditions6
Atopic dermatitis and skin infections are a poorly documented crisis in Canada's Indigenous pediatric population: It's time to start the conversation6
A systematic scoping review of racial, ethnic, and socioeconomic health disparities in pediatric dermatology6
Disparities in telemedicine use during the COVID‐19 pandemic among pediatric dermatology patients6
Infliximab for the treatment of recalcitrant bullous Sweet syndrome in a 10‐year‐old girl6
Novel use of Autoinflammatory Diseases Activity Index (AIDAI) captures skin and extracutaneous features to help manage pediatric DITRA: A case report and a proposal for a modified disease activity ind6
Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X‐linked (IPEX) syndrome6
Successful treatment of a 3‐year‐old girl with generalized pustular psoriasis using secukinumab monotherapy6
Infantile toxic epidermal necrolysis: Successful treatment of an 8‐week‐old with intravenous immunoglobulin and amniotic membrane transplant6
Proliferating pilomatricoma in a 9‐year‐old girl6
Toxic epidermal necrolysis and Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25‐year retrospective study at a single te6
Alopecia universalis after drug reaction with eosinophilia and systemic symptoms (Dress)6
Eosinophilic cellulitis in response to BNT162b2 COVID‐19 vaccination6
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge5
Multifocal infantile hemangiomas associated with concomitant giant hepatic rapidly involuting congenital hemangioma5
Skin and Mucosal Manifestations in NEMO Syndrome: A Case Series and Literature Review5
Pediatric epidermolysis bullosa acquisita: A review5
The case of missing skin: Congenital Volkmann ischemic contracture5
Hereditary fibrosing poikiloderma (POIKTMP syndrome) report of a new mutation and review of the literature5
Catastrophic congenital hemangioma with severe coagulopathy leading to fatal cardiac failure: Case report and review5
Widespread cutaneous eruption after aluminum‐containing vaccination: A case report and review of current literature5
Decreases in scabies and lice cases among the pediatric and adult populations during COVID‐195
A case of wild‐type rubella‐associated cutaneous granuloma in ataxia telangiectasia5
Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome5
Epidermolysis bullosa with pyloric atresia associated with compound heterozygous ITGB4 pathogenic variants: Minimal skin involvement but severe mucocutaneous disease5
CARMIL2‐related immunodeficiency manifesting with photosensitivity5
Clinical, trichoscopy, and light microscopic findings in hypohidrotic ectodermal dysplasia: Report of 21 patients and a review of the literature5
Interventions to improve primary care provider management of atopic dermatitis: A systematic review5
Staphylococcal toxic shock syndrome in a child with interleukin‐17 inhibitor treatment for psoriasis5
Ichthyosis follicularis, atrichia and photophobia (IFAP) and hereditary mucoepithelial dysplasia: Two syndromes that share a common clinical spectrum5
Folliculocystic and collagenous hamartoma of tuberous sclerosis complex, not always a single cutaneous lesion5
Psychosocial impact of epidermolysis bullosa on patients: A qualitative study5
Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin5
Acral peeling as the sole skin manifestation of COVID‐19 in children5
Thoracoscopic sympathicotomy for the treatment of intolerable palmar and axillary hyperhidrosis in children is associated with high recurrence rates5
Management of tinea capitis in Israel: A comparative study5
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines5
Continuing patient care to underserved communities and medical education during the COVID‐19 pandemic through a teledermatology student‐run clinic5
Parental atopy and risk of atopic dermatitis in the first two years of life in the BASELINE birth cohort study5
Treatment of pruritus with botulinum toxin in a pediatric patient with Fox‐Fordyce disease5
Patch testing in skin of color: A brief report5
Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy5
Disseminated cutaneous tuberculosis from BCG vaccination site in an immunocompetent child5
5
Topical triamcinolone induced Cushing syndrome: A case report5
Keratinocytic epidermal nevi associated with localized fibro‐osseous lesions without hypophosphatemia5
“Accutane Check”: Insights into youth sentiment toward isotretinoin from a TikTok trend5
Retrospective case series of increased oral propranolol dosage for infantile hemangiomas5
Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol5
Dermoscopic characteristics of acral melanocytic nevi in children and adolescents5
Pruritus assessment tools for 6 to 7‐year‐old children: KidsItchyQoL and ItchyQuant5
Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population5
Clinical and histologic presentation of pediatric reactive granulomatous dermatitis5
Rapid response to secukinumab in a 5‐year‐old with deficiency of the interleukin‐36 receptor antagonist (DITRA) with severe scalp and nail involvement5
Necrobiosis lipoidica with rapid response to doxycycline4
Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic dermatitis4
Atopic dermatitis‐like graft‐versus‐host disease treated with dupilumab4
The natural history of laryngo‐onycho‐cutaneous syndrome: A case series of six pediatric patients and literature review4
Topical cidofovir for the treatment of recalcitrant viral warts and molluscum contagiosum in Jacobsen syndrome4
Do clinical severity scores correlate with the quality of life in children with psoriasis? A cross‐sectional study of Iranian pediatric patients4
Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome4
A case report of PHF6 mosaicism: Beyond the classic Börjeson‐Forssman‐Lehmann syndrome4
Comparing clinical acne vulgaris severity to adolescent and parent perceptions of acne severity and impact on quality of life4
Manifestation of anxiety and depression among pediatric patients with psoriasis: A review4
Inflammatory bowel disease presenting with pyodermatitis‐pyostomatitis vegetans in a pediatric patient: A case report and review of the literature4
Delayed diagnosis of holocarboxylase synthetase deficiency in three patients with prominent skin findings4
Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A two‐year case series of patient‐reported outcomes4
Report of a case of RAVEN, hair heterochromia and autism in the setting of FGFR2 mutation4
Acute inflammatory Demodex‐induced pustulosis in an immunocompetent patient related to topical steroid use4
A case of pediatric lymphomatoid papulosis treated with photodynamic therapy and narrowband ultraviolet B4
The spectrum of pediatric scarring alopecia: A retrospective review of 27 patients seen at Mayo Clinic4
Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations4
A unique variant of juvenile papular‐purpuric gloves and socks syndrome4
Pediatric trichodysplasia spinulosa: A report of 2 cases and review of the literature4
The scope of health insurance coverage of vitiligo treatments in the United States: Implications for health care outcomes and disparities in children of color4
Skin of color images in pediatric dermatology textbooks4
Pediatric morphea state‐of‐the‐art literature review: Reframing morphea as a systemic disease4
Parent report of sleep health and attention regulation in a cross‐sectional study of infants and preschool‐aged children with atopic dermatitis4
Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate4
Photodocumentation in skin of color4
A novel ENPP1 mutation identified in a multigenerational family affected by Cole disease4
Acute generalized exanthematous pustulosis in children and adolescents in Singapore: A ten‐year retrospective review4
Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy4
A case of severe nivolumab‐induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma4
Acetaminophen‐induced generalized fixed drug eruption in a 5‐year‐old girl4
Diagnosing Omenn syndrome4
Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV/V adolescent population4
Examination of use and barriers for five sun protection strategies in parents and their children4
Treatment of scarring alopecia from trauma and surgical procedures in young patients using follicular unit hair transplantation4
Hypophosphatemic rickets: A rare complication of congenital melanocytic nevus syndrome4
Segmental congenital hemangiomas: Three cases of a rare entity4
Development of an artificial intelligence algorithm for the diagnosis of infantile hemangiomas4
Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population4
Low dose oral corticosteroids, microneedling, and topical 5‐fluorouracil: A novel treatment for recalcitrant pediatric vitiligo4
A case of unilateral linear capillaritis4
Switching biologics in children with psoriasis: Results from the BiPe cohort4
Angioedema: A potential complication of dupilumab in atopic dermatitis4
PLACK syndrome resulting from a novel homozygous variant in CAST4
Cutaneous granulomas as the presenting manifestation of Griscelli syndrome type 24
“Live Sun Smart!” Testing the effectiveness of a sun safety program for middle schoolers4
4
Pediatric melanoma in the Hispanic population: An analysis of institutional and national data4
Duration of neonatal intensive care unit exposure associated with decreased risk of atopic dermatitis4
Review article: Emerging issues in pediatric skin of color, part 14
Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient4
Transient abdominal telangiectasia of the newborn4
Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS‐C4
Anogenital warts and relationship to child sexual abuse: Systematic review and meta‐analysis4
Tips for addressing common conditions affecting pediatric and adolescent patients with skin of color4
0.04925012588501